[The drug industry: a national issue].
Following up on a letter received from the Mrs. Nicole Fontaine, the Delegate Minister of Industry, requesting recommendations concerning the "serious threats" to the French drug industry, the Academy of Medicine auditioned the five leading French pharmaceutical firms and two foreign firms. Their complains led to proposals for six recommendations: recognize the strategic importance of the drug industry, conclude several years of contracts between the Economic committee on health products and the drug industry, facilitate clinical trails of drugs in France, favor relations between the national drug industry and university research centers, Inserm, Cnrs and the administration, encourage the development of biotechnology firms which represent one of the most promising areas of therapeutic research, propose the creation of an interministerial drug counsel presided by the Prime Minister to establish and implement a common national strategy.
Hollender
L
L
Académie nationale de médecine, 16, rue Bonaparte, F75272 Paris Cedex 06.
D000046:Academic Medical Centers; D001709:Biotechnology; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000639:trends*; D005602:France; D012106:Research